Skip to content

Does LAH May Improve the Pregnancy Outcomes?

Does Laser-assisted Hatching(LAH) May Improve the Pregnancy Outcomes in Human?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03810157
Enrollment
1200
Registered
2019-01-18
Start date
2018-12-26
Completion date
2019-11-01
Last updated
2019-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Outcomes

Keywords

laser-assisted hatching (LAH), zona pellucida, cryopreservation, pregnancy outcomes

Brief summary

A defect in the hatching stage is considered an important cause of implantation failure. Therefore, assisted hatching (AH), which involves artificial disruption of the zona pellucida, has been proposed as a method for improving the capacity of the embryo to implant. But the advantage of using laser to facilitate the hatching process of embryos in ART practice is debatable, and an optimum strategy for performing LAH remains elusive. Therefore, the aim of this study was to evaluate the effects of laser-assisted hatching(LAH) on clinical outcomes. Patients were randomly divided into control and LAH groups. The zona pellucida was thinned or drilled with a diode laser. Relevant parameters are recorded to evaluate the validity of LAH in ART.

Detailed description

Hatching is a very important process for successful implantation involving the breaking of the embryo out of the zona pellucida at the blastocyst stage. Inadequate hatching of the blastocyst might lead to implantation failure in ART. Currently, a variety of AH techniques have been used including zona thinning and the opening or complete removal of the zona by laser. But the advantage of using laser to facilitate the hatching process of embryos in ART practice is debatable, and an optimum strategy for performing LAH remains elusive. Therefore, the investigator aim to discuss the effectiveness of LAH in ART. In this study, patients were randomly divided into control and LAH groups. A quarter of zona pellucida of the cleavage-stage embryo was thinned to 6.6 μm. All operation was performed in the empty region without contact to the blastomere in order to minimize the blastomere damage. The ZP of blastocyst was drilled with laser, the ZP opening 20% of its initial length. The operation was performed in the opposite region of ICM in order to minimize the damage. In the control group, embryos were transplanted without LAH. The rate of clinical pregnancy, live-birth, miscarriage, multiple gestation were evaluated. This research intends to discuss whether LAH can improve the clinical outcomes in ART, and further choice the appropriate LAH action site.

Interventions

DEVICELaser-assisted hatching system

The ZP was thinned or drilled with the Laser-assisted hatching system. The laser pulse was 0.296 ms. Laser aperture was 8μm.

Sponsors

Tang-Du Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
22 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing IVF/ICSI-ET cycle; * The zone pellucida of the cleavage-stage embryo is thicker than 8 μm.

Exclusion criteria

* Number of embryos transferred per cycle \>2; * The transferred embryos including fresh and frozen cycle in the same cycle; * Embryos developed from the frozen-thawed oocytes.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of LAH in ART6 monthsAssess the clinical pregnancy

Secondary

MeasureTime frameDescription
Feasibility of LAH in ART1 yearIncidence of LAH adverse events was assessed by miscarriage rate and multiple gestation rate.

Countries

China

Contacts

Primary ContactMing Wang
wangmingbio@snnu.edu.cn8613259809290

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026